Loring Wolcott & Coolidge Fiduciary Advisors LLP MA cut its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 22.4% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,221 shares of the pharmacy operator’s stock after selling 10,163 shares during the quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Walgreens Boots Alliance were worth $1,265,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the company. Northern Oak Wealth Management Inc. grew its stake in shares of Walgreens Boots Alliance by 54.1% in the second quarter. Northern Oak Wealth Management Inc. now owns 715 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 251 shares during the period. Ancora Advisors LLC grew its stake in shares of Walgreens Boots Alliance by 1.2% in the second quarter. Ancora Advisors LLC now owns 21,734 shares of the pharmacy operator’s stock worth $921,000 after acquiring an additional 253 shares during the period. Horrell Capital Management Inc. grew its stake in shares of Walgreens Boots Alliance by 0.8% in the second quarter. Horrell Capital Management Inc. now owns 32,178 shares of the pharmacy operator’s stock worth $1,364,000 after acquiring an additional 267 shares during the period. Highland Capital Management LLC grew its stake in shares of Walgreens Boots Alliance by 0.9% in the second quarter. Highland Capital Management LLC now owns 30,344 shares of the pharmacy operator’s stock worth $1,286,000 after acquiring an additional 275 shares during the period. Finally, KLCM Advisors Inc. grew its stake in shares of Walgreens Boots Alliance by 1.1% in the second quarter. KLCM Advisors Inc. now owns 26,269 shares of the pharmacy operator’s stock worth $1,114,000 after acquiring an additional 280 shares during the period. Hedge funds and other institutional investors own 55.96% of the company’s stock.

WBA stock opened at $37.41 on Friday. Walgreens Boots Alliance Inc has a one year low of $33.88 and a one year high of $64.50. The company’s fifty day moving average price is $36.42 and its 200-day moving average price is $40.52. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.33 and a current ratio of 0.69. The company has a market capitalization of $32.42 billion, a PE ratio of 45.62, a price-to-earnings-growth ratio of 1.35 and a beta of 0.43.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, October 15th. The pharmacy operator reported $1.02 EPS for the quarter, topping the consensus estimate of $0.96 by $0.06. Walgreens Boots Alliance had a net margin of 0.55% and a return on equity of 19.43%. The firm had revenue of $34.75 billion for the quarter, compared to the consensus estimate of $34.36 billion. During the same quarter in the previous year, the firm earned $1.43 earnings per share. The company’s quarterly revenue was up 2.3% compared to the same quarter last year. On average, research analysts predict that Walgreens Boots Alliance Inc will post 4.68 EPS for the current fiscal year.

Several analysts recently issued reports on WBA shares. Morgan Stanley cut their target price on shares of Walgreens Boots Alliance from $45.00 to $40.00 and set an “equal weight” rating for the company in a research report on Thursday, September 3rd. Raymond James restated a “hold” rating on shares of Walgreens Boots Alliance in a research report on Monday, September 7th. Royal Bank of Canada cut their target price on shares of Walgreens Boots Alliance from $45.00 to $38.00 and set a “sector perform” rating for the company in a research report on Wednesday, September 2nd. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “strong sell” rating and set a $42.00 target price for the company. in a research report on Friday, July 17th. Finally, Citigroup cut their target price on shares of Walgreens Boots Alliance from $43.00 to $40.00 and set a “neutral” rating for the company in a research report on Friday. Five research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the company’s stock. Walgreens Boots Alliance presently has a consensus rating of “Hold” and an average price target of $43.19.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Article: Limitations to arbitrage trading

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.